Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2026-01-29 @ 12:25 AM
Study NCT ID:
NCT00087061
Status:
COMPLETED
Last Update Posted:
2013-07-18
First Post:
2004-07-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
SIGMATAU-ST-01-402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |